Pelthos Therapeutics (PTHS) Net Cash Flow (2023 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Net Cash Flow of $3.8 million for Q4 2025, up 608.09% year-over-year from $532421.0 in Q4 2024, and down 67.03% quarter-over-quarter from $11.4 million in Q3 2025.
Pelthos Therapeutics (PTHS) Net Cash Flow (2023 - 2026) Analysis & Trends
Pelthos Therapeutics' Net Cash Flow history runs 3 years deep, the most recent figure standing at $3.8 million for Q4 2025.
- In Q4 2025, Net Cash Flow rose 608.09% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $14.7 million (up 3436.93% YoY), while the FY2025 annual figure was $17.5 million, up 4099.04% from the prior year.
- Net Cash Flow for Q4 2025 stood at $3.8 million, down from $11.4 million in the prior quarter.
- The five-year high for Net Cash Flow was $11.4 million in Q3 2025, with the low at -$1.4 million in Q2 2024.
- The 3-year median for Net Cash Flow is -$32786.5 (2023), against an average of $1.3 million.
- Peak annual rise in Net Cash Flow reached 56917.79% in 2024, while the deepest fall reached 4201.34% in 2024.
- Pelthos Therapeutics' Net Cash Flow stood at $73605.0 in 2023, then plunged by 1108.08% to -$742000.0 in 2024, then jumped by 608.09% to $3.8 million in 2025.
- Business Quant data shows PTHS's Net Cash Flow at $3.8 million in Q4 2025, $11.4 million in Q3 2025, and -$72145.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Pelthos Therapeutics | 91.09 Mn | 66.53 Mn | 21.23 Mn | 6.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.54 Mn |
| Jun 30, 2026 | 6.54 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 11.43 Mn |
| Sep 30, 2025 | 11.43 Mn |
| Jun 30, 2025 | -72,145.00 |
| Jun 30, 2025 | -72,145.00 |
| Mar 31, 2025 | -382,126.00 |
| Mar 31, 2025 | -382,126.00 |
| Dec 31, 2024 | -742,000.00 |
| Dec 31, 2024 | -742,000.00 |
| Sep 30, 2024 | -1.15 Mn |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | -1.37 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Dec 31, 2023 | 73,605.00 |
| Dec 31, 2023 | 73,605.00 |